Tinnitus is a persistent non-physiologic, non-psychiatric, ringing in the ear that affects up to 20% of the general US population. The purpose of this study is to assess the patient reported effectiveness of Xeomin (incobotulinumtoxinA) injections into the auricular muscles for relief of tinnitus with use of the Tinnitus Handicap Inventory questionnaire.
1 Primary · 0 Secondary · Reporting Duration: pre-injection baseline to 4-6 weeks post injection
Experimental Treatment
Non-Treatment Group
33 Total Participants · 2 Treatment Groups
Primary Treatment: Incobotulinium toxin A group · Has Placebo Group · Phase 2
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Minnesota | 50.0% |
Pennsylvania | 50.0% |
Did not meet criteria | 100.0% |
0 | 50.0% |
3+ | 50.0% |